Mackenzie Financial Corp trimmed its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 50.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,873 shares of the pharmacy operator’s stock after selling 2,888 shares during the quarter. Mackenzie Financial Corp’s holdings in Walgreens Boots Alliance were worth $209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Andra AP fonden boosted its stake in Walgreens Boots Alliance by 6.9% during the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after buying an additional 4,000 shares in the last quarter. Chesley Taft & Associates LLC lifted its holdings in shares of Walgreens Boots Alliance by 48.6% during the fourth quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after acquiring an additional 85,423 shares during the period. First Trust Advisors LP raised its holdings in shares of Walgreens Boots Alliance by 10.3% in the fourth quarter. First Trust Advisors LP now owns 748,421 shares of the pharmacy operator’s stock valued at $54,350,000 after buying an additional 69,650 shares during the last quarter. CI Investments Inc. bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at about $27,555,000. Finally, Burgundy Asset Management Ltd. raised its holdings in shares of Walgreens Boots Alliance by 0.4% in the fourth quarter. Burgundy Asset Management Ltd. now owns 5,499,193 shares of the pharmacy operator’s stock valued at $399,351,000 after buying an additional 23,997 shares during the last quarter. 60.94% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:WBA traded down $1.18 during mid-day trading on Friday, hitting $63.47. 5,035,466 shares of the company traded hands, compared to its average volume of 5,968,438. The stock has a market cap of $64,964.02, a price-to-earnings ratio of 12.45, a PEG ratio of 1.06 and a beta of 1.16. Walgreens Boots Alliance Inc has a 12-month low of $61.74 and a 12-month high of $87.79. The company has a quick ratio of 0.45, a current ratio of 0.90 and a debt-to-equity ratio of 0.44.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.18. The business had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. Walgreens Boots Alliance’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same period last year, the company posted $1.36 earnings per share. equities research analysts expect that Walgreens Boots Alliance Inc will post 5.95 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.52%. Walgreens Boots Alliance’s payout ratio is presently 31.37%.
In other news, insider Stefano Pessina bought 98,858 shares of the stock in a transaction on Monday, January 15th. The shares were purchased at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 14.80% of the company’s stock.
Several brokerages recently issued reports on WBA. Jefferies Group set a $85.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday. Royal Bank of Canada set a $88.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Wednesday, March 28th. They noted that the move was a valuation call. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, March 29th. Scotiabank dropped their price objective on Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, Needham & Company LLC restated a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $84.14.
ILLEGAL ACTIVITY WARNING: “Walgreens Boots Alliance Inc (WBA) Position Reduced by Mackenzie Financial Corp” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/04/07/mackenzie-financial-corp-has-209000-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.